Professor Stephan Schug is currently Professor and Chair of Anaesthesiology in the School of Medicine and Pharmacology at the University of Western Australia and Director of Pain Medicine at the Royal Perth Hospital, Australia. He also maintains a position as Honorary Professor of Anaesthesiology at the University of Auckland, New Zealand.
Prof Schug studied Medicine at the University of Cologne, Germany, where he also obtained his MD by thesis in clinical pharmacology and subsequently specialised in anaesthesia, intensive care and pain medicine.
Very early in his career, he focussed his clinical and research interests on the treatment of patients in pain.
In Prof Schug's current position as Director of Pain Medicine in the Department of Anaesthesia and Pain Medicine of Royal Perth Hospital, his clinical responsibilities include running of a Comprehensive Inpatient Pain Service at two sites of this hospital as well as a multi-disciplinary Pain Medicine Centre, which is accredited for training by the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists.
Dr Bob Rappaport joined the neurology division at US FDA’s Center for Drug Evaluation and Research in 1994, where he spent a few years developing expertise in drug regulatory science, drug product development, and clinical trial design and analysis. He was promoted to Deputy Division Director of the FDA Division of Anesthesia, Analgesia, and Addiction Products in 1998. In 2002, he was appointed Director of the same Division, where he remained until his retirement in October 2014.
Throughout his tenure, he was an advocate for the development of novel analgesic, anesthetic and addiction drug products, and instituted new standards for the study of these drugs. Dr Rappaport was also a key player in the FDA’s continued efforts to encourage and assist the development of abuse-deterrent opioid formulations, and oversaw the updated guidance on the development of analgesic drug products.
In 2013, Dr Rappaport received FDA’s Lifetime Achievement Award for his work in advancing the fields of anesthesia, analgesia and addiction. In May 2015, he received the 2015 John and Emma Bonica Public Service Award from the American Pain Society, which recognises distinguished contributions to the field of pain through public services or other efforts that further knowledge about pain.
Dr Rappaport completed his medical training at The George Washington University School of Medicine and Health Sciences, and is board certified in neurology and sleep medicine.
Professor Bruce Sunderland is the Emeritus Professor at the School of Pharmacy, Curtin University of Technology in Perth, Western Australia where he specialises in drug delivery and drug stability research areas.
Prof Sunderland has over 40 years experience as an academic pharmacist, teaching and researching in physical pharmacy, pharmaceutical technology and medicine formulation. He has been involved in supervising a broad range of research projects, including implant drug delivery systems and drug stability. He has published over 130 research publications in peer-reviewed journals.
Prof Sunderland holds a Bachelor of Pharmacy from Curtin University, a Postgraduate Diploma in Pharmaceutical Technology from the University of London and a Doctor of Philosophy from the University of Western Australia. He is a Fellow of the Pharmaceutical Society of Australia and a Member of the Society of Hospital Pharmacists of Australia (Honoris Causa).
Professor Stephen Lim is an Adjunct Professor in the School of Pharmacy at Curtin University and has more than 34 years experience in the hospital and commercial pharmacy sectors. His interest is mainly in research, drug safety and drug delivery, especially in the area of needle-less systems.
Prof Lim is also an expert in drug storage and extending the shelf-life of medication. He completed his Master thesis by looking at drug stability in the frozen state and has shown that intranasal fentanyl delivery is as effective as intravenous fentanyl.
Prof Lim obtained a Bachelor of Pharmacy (with distinctions), a Master of Pharmacy and a Ph.D. in Pharmacy in novel, drug delivery system from Curtin University.
Dr Yandi Liu has been working in pharmaceutical research areas for more than 25 years and has accumulated a wealth of experience from both industry and university laboratories.
Dr Liu's research interests include controlled drug delivery systems, pharmacology and toxicology of natural products, mass spectrometry of bioactive molecules, analytical and structural biochemistry.
Dr Liu has a Bachelor of Science (Pharmacy) from Henan University, China (1986), and obtained his PhD from Curtin University of Technology, Western Australia.
He is currently an honorary Research Fellow with the School of Pharmacy at Curtin University.